#immunotherapy
2 articles with this tag
FinanceDBV Tech: Cash Runway Masks High Stakes for VIASKIN®
Uncover the hidden risks behind DBV Tech's $288M cash runway. Our analysis reveals how VIASKIN®'s success dictates the company's future & allergy treatment...
ScienceCaffeine & CRISPR: A New Signal for Gene Editing Control
Unlock gene editing's potential! Experts reveal how caffeine could revolutionize CRISPR, offering unprecedented control & precision for targeted therapies....